Inventor · disambiguated record
Zhihua Ma
Also filed as: MA ZHIHUA
31 granted patents·10 pending applications·229 citations·filing 2005–2024
97Inventor score
Top patents by PatentIndex Score
41 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US10058550B2Methods of treating heart failureAMGEN INC·Filed 2017·Granted Aug 28, 2018·13 cites·81 claims
- 0497US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0597US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0697US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0795US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0895US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 0995US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1094US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 1190US10150760B2Compounds for use in preparing heterocyclic triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Dec 11, 2018·8 cites·29 claims
- 1289US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 1389US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 1488US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 1588US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1687US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1786US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1885US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 1983US7687526B2Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2007·Granted Mar 30, 2010·5 cites·18 claims
- 2082US12371414B2Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·6 claims
- 2182US11993580B1Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2023·Granted May 28, 2024·0 cites·6 claims
- 2280US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 2380US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 2478US7465804B2Compounds, pharmaceutical compositions and methods for their use in treating metabolic disordersAMGEN INC·Filed 2006·Granted Dec 16, 2008·3 cites·48 claims
- 2574US10906890B2Triazole phenyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Feb 2, 2021·1 cites·20 claims
- 2674US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2773US11020395B2Cycloalkyl substituted triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 1, 2021·1 cites·26 claims
- 2873US10689367B2Triazole pyridyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 23, 2020·1 cites·30 claims
- 2973US8748462B2Spirocyclic GPR40 modulatorsBROWN SEAN P·Filed 2009·Granted Jun 10, 2014·2 cites·25 claims
- 3073US8003648B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2009·Granted Aug 23, 2011·1 cites·10 claims
- 3170US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
- 3267US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 3365US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 3464US2009275598A1Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2009·Application pending·0 cites
- 3564US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3656US7714008B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2007·Granted May 11, 2010·0 cites·11 claims
- 3753US2025188084A1Compounds and methods for modulating cdk9 activityKRONOS BIO INC·Filed 2021·Application pending·0 cites
- 3847US11191762B2Alkyl substituted triazole compounds as agonists of the APJ ReceptorAMGEN INC·Filed 2017·Granted Dec 7, 2021·0 cites·28 claims
- 3946US2007244155A1Bicyclic carboxylic acid derivatives useful for treating metabolic disordersAMGEN INC·Filed 2007·Application pending·0 cites
- 4044US11149040B2Fused triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Oct 19, 2021·0 cites·24 claims
- 4143US2010137323A1Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhihua Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →